Cutaneous Adverse Events in Patients with Chronic Hepatitis C during Treatment with Directly Acting Antiviral Agents: A cohort study

Incidence of Acute Kidney Injury in HCV Infected Patients Receiving Direct-Acting Antivirals

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Frequency of Hepatocellular Carcinoma in HCV Patients Treated with Direct-Acting Antiviral Drugs

Hematological Effects of Antiviral Drugs for Hepatitis C Virus

A real-life experience of dermatological manifestations associated with direct-acting antivirals for chronic hepatitis C virus infection

Occurrence of hepatocellular carcinoma following direct antiviral agents (DAA) therapy

Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter s

Direct Acting Anti-Viral Therapy, and Potential Increase in the Incidence of Hepato-Cellular Carcinoma in Cirrhotic Patients With Hepatitis C Virus